https://the483.com/flex-bank-charter-fdic-application/ The 483 en 2026-07-26T09:58:39.000Z Flex Files for Bank Charter on $40B Rent Book https://the483.com/cisa-circia-rule-300000-firms/ The 483 en 2026-07-26T09:14:39.000Z CISA Blows Two Deadlines on Rule for 300,000 Firms https://the483.com/cfpb-johnson-capital-one-conflict/ The 483 en 2026-07-26T09:00:22.143Z Grilled: CFPB Nominee's $2B Capital One Conflict https://the483.com/visa-stablecoin-platform-land-grab/ The 483 en 2026-07-25T21:04:39.000Z Visa Opens Stablecoin Platform as Rivals Pile In https://the483.com/amgen-tavneos-fda-hearing/ The 483 en 2026-07-25T10:15:52.000Z Amgen fights to save $3.7B Tavneos from FDA ax https://the483.com/epa-cuts-comment-data-center-permits/ The 483 en 2026-07-25T09:32:01.000Z EPA Moves to Gut Comment Rule on Data Center Permits https://the483.com/paramount-delays-warner-bros-deal/ The 483 en 2026-07-25T08:54:30.000Z Paramount Delays $111B Warner Bros Deal to 2027 https://the483.com/upstart-conditional-bank-charter-occ/ The 483 en 2026-07-24T22:22:04.000Z Upstart Clears OCC's Bar for a National Bank Charter https://the483.com/occ-denies-wise-trust-charter/ The 483 en 2026-07-24T21:48:47.000Z OCC Rejects Wise's Trust Bank Bid Over AML Gaps https://the483.com/yescarta-stxbp2-toxicity-gene/ The 483 en 2026-07-24T21:22:58.000Z Predicted Toxicity in All 6 STXBP2-Mutant Yescarta Cases https://the483.com/sanofi-scraps-amlitelimab-kymab-bet/ The 483 en 2026-07-24T20:52:42.000Z Sanofi Scraps Amlitelimab After $1.4B Kymab Bet Sours https://the483.com/fpf-colorado-ai-chatbot-rulemaking/ The 483 en 2026-07-24T20:44:00.044Z Pushes Colorado to Clarify AI Chatbot Rules Before 2027 https://the483.com/scribe-therapeutics-129m-ipo/ The 483 en 2026-07-24T10:39:51.000Z Scribe Prices Upsized $129M IPO, Sanofi Buys More